CMDF

AcronymDefinition
CMDFCapital Market Development Fund
CMDFCanadian Medical Discoveries Fund, Inc.
CMDFCombined Miniature Deterrent Forces (science-fiction film Fantastic Voyage)
CMDFChildren's Motility Disorder Foundation
CMDFCombined Main Distribution Frame (Sprint)
CMDFCatalog Master Data File
CMDFContract Monitoring Data File
CMDFCommunity and Media Development Fund (Belarus)
References in periodicals archive ?
Both the original CMDF and resin-infused samples displayed the abrupt fracture behavior typical of brittle materials as shown by their tensile stress-strain profiles (Fig.
The tensile properties of the original CMDF were considerably improved after resin infusion (Table 1), with tensile strength increasing 434 percent and 235 percent for the epoxy-infused CMDF and phenolic-infused CMDF, respectively, and the tensile modulus increasing 138 percent and 97 percent for the epoxy-infused and phenolic-infused samples, respectively.
Under the terms of the transaction, CMDF and the other investors have been granted warrants to acquire 500,000 common shares of Spectral at an exercise price of $3.
This additional investment by OTPP and CMDF will increase the cash payable to Nexia by PharmAthene.
Established in 1994 and available across Canada, CMDF has venture capital investments in approximately 48 companies involved in health sciences, biotechnology, diagnostics, medical devices, drug discovery and development, health care delivery services and e-health.
CMDF continues to hold options to acquire an additional 535,700 common shares of Drug Royalty of which one-half are exercisable at $2.
So, too, is the market for effective therapeutics, which is expected to top $16 billion by the year 2000, according to Frank Gleeson, Senior Vice-President of CMDF and Senior Vice-President of MDS Health Ventures Capital Corp.
CMDF made the loan and acquired the private-placement warrants for general investment purposes.
In addition to the issuance of common shares, CMDF received warrants to acquire 803,550 common shares of Drug Royalty of which one-third are exercisable at $2.
9 million to CMDF through the issuance of approximately 617,000 shares of GZMO stock valued at $6.
In addition to the issuance of common shares, CMDF will receive warrants to acquire 803,550 common shares of Drug Royalty of which one-third are exercisable at $2.
The Company's intention to buy-out CMDF was disclosed in August.